WuXi PharmaTech
From China Stock Market
From Reuters: WuXi PharmaTech (Cayman) Inc. (WuXi) is a China-based pharmaceutical and biotechnology research and development outsourcing company. The Company provides a portfolio of chemistry, biology and manufacturing services in the drug discovery and development process to pharmaceutical and biotechnology companies. Its core operations are grouped into two segments: laboratory services and manufacturing. The Company's laboratory services segment consists of discovery chemistry, service biology, analytical, pharmaceutical development and process development services. The manufacturing segment focuses on manufacturing of advanced intermediates and active pharmaceutical ingredients (APIs). During the year ended December 31, 2006, the Company provided its services to 70 pharmaceutical and biotechnology customers.
Contents |
How To Invest
WuXi PharmaTech (Cayman) Inc. is traded on the NYSE under stock symbol WX.
Competitors
Pharmaceutical Product Development, Inc. (PPD) in the United States offers similar services to the pharmaceutical and biotechnology customers.
Key Development
- WuXi PharmaTech completed its IPO in US Market, raising over $160 million in August, 2007.
Other Stocks
